3/25/19: Prior to joining Lantheus in May 2018, John Bolla spent 20 years at GlaxoSmithKline plc (GSK), a global branded pharmaceutical company. He held various senior leadership roles at GSK, including Vice President, Supply Chain, North America, where he was responsible for leading all manufacturing, supply planning, logistics and distribution for GSK’s largest global market.
3/25/19: The ConvertX® Biliary Stent System is the first system to provide interventional radiologists with a percutaneous plastic biliary stent option. The system is designed to eliminate the need for the second invasive procedure and the associated risk, cost, and time.
3/25/19: The HeartLight X3 System is a third generation technology building upon the advanced features of the HeartLight Endoscopic Ablation System, which performs pulmonary vein isolation (PVI) using laser energy to create lines of scar tissue to block the abnormal electrical pathways that cause AFib.
3/25/19: Real-world data will be collected from up to 30 centers throughout the world on the technical aspects of the procedure including ablation time under varying liver tissue and lesion conditions.
3/24/19: “Tennis elbow can be difficult to treat, leaving many patients unable to perform the simplest tasks, such as picking up their children, cooking dinner, or even working on a computer. With this frustration, many patients turn to invasive major surgery after years of failed physical therapy and medication use,” said Yuji Okuno, MD, PhD, founder of the Okuno Clinic in Japan and lead author of the study. “We were interested to see if this technique, already in use in other areas of the body, would be effective for this common, debilitating condition and help people immediately regain a range of motion that many of us take for granted in our everyday tasks.”
3/24/19: Offers a conversational voice interface that allows interventional radiology (IR) physicians to ask questions and retrieve information needed for their patient treatments without breaking sterile scrub
3/22/19: VentriFlo revolutionizes circulatory technology by delivering a life-like pulse to a patient during heart surgery and during post-surgical support when their own heart is unable to provide a native pulse.